'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL

计划入组 111 人 · 首次发布于 2025 年 2 月 19 日

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

计划入组 10,000 人 · 首次发布于 2019 年 2 月 22 日

Effects of Ocrevus in Relapsing Multiple Sclerosis

计划入组 60 人 · 首次发布于 2020 年 5 月 14 日

Torpedo

Microbiome Platform

Gut'Innov platform(Da Volterra)

European Thoracic Oncology Platform

Switzerland

Evaxion Biotech

Denmark

YZYBIO-B

China

C4 Therapeutics and Roche Expand Partnership with $1 Billion+ DAC Collaboration

C4 Therapeutics Announces 2025 Milestones for Oncology-Focused Degrader Medicines

FDA Accepts IND Application for BIIB142, First IRAK4 Degrader to Enter Clinical Development for Autoimmune Diseases